Editorial☆
Article Outline
- The McGill consensus statement on overdentures** *This statement is supported by published studies that form the basis of material to be published as: Feine JS, Carlsson GE, editors. Mandibular 2-implant overdentures as minimum standard of care for edentulous patients. Chicago: Quintessence Publishing (forthcoming).
- Copyright
On May 24 and 25, 2002, a symposium was held at McGill University in Montreal, Quebec, Canada, during which scientists and expert clinicians presented 15 papers on the efficacy of overdentures for the treatment of edentulous patients. Strong emphasis was placed on evidence from randomized controlled trials in which mandibular 2-implant overdentures were compared with conventional dentures.
A panel of experts who work in areas relevant to this topic, along with patients and clinical trial participants who have experience with dental prostheses, prepared a consensus statement declaring mandibular 2-implant overdentures the first-choice standard of care for edentulous patients. The statement was based on (1) presentations given by the aforementioned experts during a 1.5-day session, (2) available scientific knowledge on this topic, and (3) the personal experience of the patients/participants.
A draft consensus statement was circulated to all presenters, to subjects who participated in some of the clinical trials, and to other edentulous individuals who attended the symposium. The statement was modified during the meeting in light of their comments.
We hope that the final version of the consensus statement will serve as a guideline for clinicians and patients and that it will stimulate discussion within and among professional organizations, health authorities, and third-party payers. The statement is an independent report and is not a policy statement for any profit-making body or business.
The McGill consensus statement on overdentures*
Most industrialized countries are experiencing a rapid decline in tooth loss. However, tooth loss increases with age, so the number of edentulous people within these societies will continue to increase for several decades because of the increase in mean age. Complete maxillary and mandibular dentures have been the traditional standard of care for edentulous patients for more than a century. Complete denture wearers are usually able to wear an upper†denture without problems, but many struggle to eat with the complete lower† denture because it is too mobile. Scientific studies have been carried out over the past decade to determine if the benefit of a mandibular 2-implant overdenture is large enough to propose it, rather than the conventional denture, as the first treatment option.
It already has been established through longitudinal clinical studies, structured reviews, and consensus conferences that the survival of root-form titanium implants is very high in the anterior mandible and that the incidence of surgical complications is very low. Furthermore, it has been shown that implants reduce the rate of resorption of the residual ridge in the anterior mandible.
Patient perspective
Conventional dentures rely on the residual alveolar ridge and mucosa for support and retention. Many patients have problems adapting to their complete dentures, especially to the mandibular prosthesis. The widespread use of denture adhesives is one indication that these prostheses are inadequate for many denture wearers. Numerous people wearing conventional dentures report that they cannot eat many foods, particularly those that are hard or tough. This forces them to change their diets in unhealthy ways and causes their nutrition to be poorer than that of people with natural teeth.
Mandibular 2-implant overdentures have been shown to be superior to conventional dentures in randomized and nonrandomized clinical trials that ranged in duration from 6 months to 9 years. Regardless of the type of attachment system used (bar, ball, magnet), patients are significantly more satisfied with 2-implant overdentures than with new conventional dentures. Patients find the implant overdentures significantly more stable, and they rate the ability to chew various foods as significantly easier. In addition, patients are more comfortable and speak more easily with implant overdentures.
Studies of several populations have shown that ratings of quality of life are significantly higher for patients who receive 2-implant overdentures (opposing complete maxillary conventional dentures) than for those with new conventional dentures.
There is emerging evidence that people who receive mandibular 2-implant overdentures modify their diets, whereas those who wear new conventional dentures do not. There is also preliminary evidence that this improves their nutritional state. Such improvements may have a strong positive impact on general health, particularly for senior adults who are vulnerable to malnutrition.
Cost
There is now conclusive evidence that oral implants may be placed in a single-stage procedure, which reduces cost. Nevertheless, the total cost of providing mandibular 2-implant overdentures is certainly greater than that of providing conventional dentures. The difference is not, however, as large as one might expect. Mandibular 2-implant overdentures should be made affordable to everyone who is edentate.
Conclusions
The evidence currently available suggests that restoration of the edentulous mandible with a conventional denture is no longer the most appropriate first-choice prosthodontic treatment. There is now overwhelming evidence that a 2-implant overdenture should become the first-choice treatment for the edentulous mandible.
- * *This statement is supported by published studies that form the basis of material to be published as: Feine JS, Carlsson GE, editors. Mandibular 2-implant overdentures as minimum standard of care for edentulous patients. Chicago: Quintessence Publishing (forthcoming).
- † †Terminology in the statement does not consistently adhere to standards established by the seventh edition of the Glossary of Prosthodontic Terms, because the statement was written for lay readers.
☆ Sweden, United Arab Emirates, Canada, New Zealand, Greece, Canada, Germany, Canada, Canada, Switzerland, Canada, Canada, Belguim, New Zealand, Canada, The Netherlands, Japan, New Zealand, USA, United Kingdom, New Zealand, The Netherlands
PII: S0022-3913(02)00065-3
doi:10.1067/mpr.2002.127883
© 2002 Editorial Council of The Journal of Prosthetic Dentistry. Published by Elsevier Inc. All rights reserved.

